pemigatinib
incyte,specialised therapeutics
 presenting final data of #fight-202 trial of #pemigatinib for patients with #cca and #fgfr2 fusions at #wcgic22. a new option for our patients approved and reimbursed also in italy! 
Associate Professor of Medical Oncology at HUNIMED, GI cancer specialist with research interest in #livercancer, #HCC, #biliarytractcancer, #cholangiocarcinoma